Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 71335-2978

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-2978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352978)

Label (Lbl713352978)
This text provides information about a medication called Mirtazapine. It states that each orally disintegrating tablet contains 30 mg of Mirtazapine USP and includes 3 mg of phenylalanine. The tablets are meant to be taken once daily and should be used immediately upon opening the container. The text also mentions storing the medication at a temperature range of 20°C-25°C and protecting it from light and moisture. Patients are advised to refer to the package insert or scan the QR code for prescribing information.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.